Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Andrea Daghero"'
Autor:
Andrea Daghero, María Laura Iglesias, Flavia Oliva, Eugenia Piasentini, Florencia Prado, Paula Balossino, Agustina Gesell, Arly Seguel, Jesica Gulmez, Camila Berardo, Sabina Carbajal, Mariana Demarchi, Melisa Echegaray, Luciana García, Caterina Gastin, Martina Llaneza, Ana Lozada, Stefania Lugrin, Florencia Martorell, Analía Mihalik, Valeria Ortiz, Paula Perlo, Ariela Portnoy, Teresita Roman, Luciana Silveira, Mariela Tornese, Ivana Villa
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3Sup, Pp 127-127 (2020)
Background: the coronavirus disease (COVID-19) pandemic has challenged the ability to do face-to-face training on advanced diabetes management technologies. Like in United States and Latinamerica, in Argentina, Medtronic Diabetes shifted from occasio
Externí odkaz:
https://doaj.org/article/3b17ec879219436394e07f437d1b5c44
P50 Short term glycemic control with a hybrid closed loop system in individuals with type 1 diabetes
Autor:
Adrián Proietti, Andrea Daghero, María Laura Kabakian, María Paula Paz Povedano, María Marcela Raggio, Graciela Rubín, Antonio Saleme, Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3Sup, Pp 155-155 (2020)
Background: Despite recent technological advances, optimal glycemic control remains a challenge in people with type 1 diabetes (T1D). Hybrid closed loop (HCL) system with algorithm-derived automated adjustment of insulin delivery aims to improve glyc
Externí odkaz:
https://doaj.org/article/c38ec77cbe594345b31d56f3be1995b7
Autor:
MATIAS CASTRO, CAMILA NICOLE CARRASCO BONILLA, JOANA C. LEON MACEDO, MARIA FERNANDA GUTIERREZ, ZEUDI C. VALERA LOPEZ, ANDREA DAGHERO
Publikováno v:
Diabetes. 71
Background and Aims: The pivotal trial of the MiniMed™ 780G system showed that optimized settings of active insulin time (2 hours) and target glucose (100mg/dL) improved glycemic outcomes.1 This study analyzed real-world glycemic outcomes of indivi
Autor:
Matias Castro, Adrián Proietti, Alejandro Daín, María Laura Kabakian, Mariela I. Echenique, Marcela Raggio, Marcial A. Angós, Antonio Saleme, Graciela Rubin, Luis Grosembacher, María Pía Santucci, Andrea Daghero, Maria Paula Paz
Publikováno v:
Diabetes. 70
Background and Aims: Despite recent technological advances, optimal glycemic control remains a challenge in people with type 1 diabetes (T1D). Hybrid closed loop (HCL) systems with automated algorithm-derived adjustment of basal insulin delivery, aim
Autor:
Silvana A. Romero Gonzalez, Jorge Waitman, Andrea Daghero, Danila P. Ré, Guillermo E. Umpierrez, Claudio Gonzalez, Gabriela Caeiro
Publikováno v:
Endocrinología, Diabetes y Nutrición. 64:92-99
Lower-income populations are hit harder by the diabetes epidemic as regards both prevalence and the risk of complications. Food Insecurity is one of the mechanisms through which poverty may predispose people with low socio-economic status to poorer c
Autor:
Flavia Oliva, Camila Berardo, Andrea Daghero, Ivana Villa, Mariela Tornese, Analía Mihalik, Martina Llaneza, Agustina Gesell, Ana Lozada, Sabina Carbajal, Caterina Gastin, María Laura Iglesias, Valeria Ortiz, Teresita Roman, Florencia Martorell, Mariana Demarchi, Arly Seguel, Paula Balossino, Paula Perlo, Florencia Prado, Luciana García, Eugenia Piasentini, Stefania Lugrin, Ariela Portnoy, Melisa Echegaray, Luciana Silveira, Jesica Gulmez
Publikováno v:
Revista de la Sociedad Argentina de Diabetes. 54:127
Introducción: el aislamiento social determinado por la pandemia de COVID-19 ha desafiado la capacidad de realizar de manera presencial la educación en tecnologías avanzadas para el manejo de la diabetes. En Argentina, al igual que en el resto de L
Autor:
Adrián Proietti, María Marcela Raggio, Antonio Saleme, Graciela Rubin, Luis Grosembacher, María Paula Paz Povedano, María Laura Kabakian, Andrea Daghero
Publikováno v:
Revista de la Sociedad Argentina de Diabetes. 54:155
Introducción: alcanzar un control glucémico óptimo en individuos con diabetes mellitus tipo 1 (DM1) sigue siendo un desafío a pesar de la incorporación de nuevas tecnologías. La automatización de la infusión de insulina a través de sistemas